Lipids, Inflammation, and CV Risk in RA

NCT02714881 · clinicaltrials.gov ↗

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Cardiovascular Disease

Interventions

DRUG: Certolizumab

Sponsor

Brigham and Women's Hospital

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)